Hôpital Morvan

Brest 29609

0 studies enrolling now · 7 studies all time

What they study most

Chronic Lymphocytic Leukemia, Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastrointestinal Stromal Tumors, Hemophilia A, Hemophilia B, Multiple Myeloma, Peripheral T-cell Lymphoma, Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer

Studies at this site

• A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06) — Running, not enrolling
• Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations — Stopped early
• A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) — Completed
• Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST) — Stopped early
• Study of Melphalan Flufenamide (Melflufen) + Dex With Bortezomib or Daratumumab in Patients With RRMM — Stopped early
• Pralatrexate vs Observation Following CHOP-based Chemotherapy in Undiagnosed Peripheral T-cell Lymphoma Patients — Stopped early
• Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe Hemophilia — Completed